KLP Kapitalforvaltning’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Buy
24,600
+14,300
+139% +$931K 0.01% 869
2025
Q4
$826K Buy
10,300
+200
+2% +$13.4K ﹤0.01% 1133
2025
Q3
$492K Hold
10,100
﹤0.01% 1402
2025
Q2
$754K Hold
10,100
﹤0.01% 1137
2025
Q1
$642K Hold
10,100
﹤0.01% 1158
2024
Q4
$789K Buy
+10,100
New +$811K ﹤0.01% 1101

Other funds holding HAE

KLP Kapitalforvaltning's HAE Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Haemonetics (HAE) stake by 139% in Q1 2026, buying an estimated $931K and bringing the position to 24,600 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #869.

KLP Kapitalforvaltning first reported a position in HAE in Q4 2024 and has held it in 6 quarters since. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • KLP Kapitalforvaltning held 24,600 shares of Haemonetics worth $1.39M as of Q1 2026.
  • KLP Kapitalforvaltning bought 14,300 Haemonetics shares in Q1 2026, an estimated $931K.
  • Haemonetics made up 0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #869 holding.
  • KLP Kapitalforvaltning first reported a position in Haemonetics in Q4 2024 and has held it in 6 quarters since.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.